Frequently asked
questions
We will be adding to the Frequently Asked Questions over time. Please drop us a note with any questions about the support we provide, application process or how you can get involved. Please also sign-up on our contact page:
Contact Us
INCATE is designed for innovators who are developing therapeutics for human infectious diseases. We are especially eager to support ventures focusing on unmet medical need, including those targeting bacterial priority pathogens as outlined by the World Health Organization.
We want to help you to build investable projects and companies that are ready for the next level of investment from industry, targeted funds, investors, and further non-dilutive funding sources.
As of 2026, our focus is on therapeutics. To give you an idea of approximate stage, we think we can help most in the following space:
- Drug projects with initial proof of concept and hit/lead identified – approximately Technology Readiness Levels (TRLs) 2-4.
Please note: Digital tools, diagnostics, and devices will not be considered.
If you aren’t sure please contact us.
No, INCATE supports ventures from around the world.
INCATE is a unique partnership for academic and industry participants that can help your innovation progress. We support innovators by:
- Providing advice from Industry Partners during and after the selection process
- Offering individualized coaching from translational academic partners and support institutions.
- Connecting ventures to a community of other innovators and partners such as investors.
- Providing non-dilutive funding that can help you answer key questions.
We believe this support allows innovators to better understand the process of creating an investible venture.
After you contact INCATE, our scouting team will decide whether your venture meets our application criteria. Learn more about who INCATE is right for here.
After this initial contact, the next step is a short meeting. This allows our team to better understand your venture and its needs, as well as to confirm you are ready to submit a Stage I application.
Stage I applications include details about how the INCATE team might support you venture during this stage. If you are chosen to apply for Stage I, you will be invited to a virtual Selection Committee Meeting which will include a short pitch and question and answer session.
If you are selected as a Stage I venture, the INCATE team will work with you on the plan you submitted in your application which may include adaptions suggested by the Selection Committee. Stage I may include sponsored support such as regulatory strategy, safety study etc. The INCATE team will also help you develop a pitch deck and plan that would form the basis of your application to INCATE Stage II.
In Stage II, ventures once again work according to a plan developed together with the INCATE team and Selection Committee. During Stage II, we support our ventures in produce the evidence needed to get support from non-dilutive funding, equity investments, or other funding bodies, such as INCATE Industry Partners, CARB-X, and GARDP.
The INCATE team supports early stage innovators who are developing therapeutics for human infectious diseases by providing advice and access to our community and events. After initially contacting INCATE, our team will help you decide whether you are ready to apply to become a Stage I venture. If so, we aim to help you prepare a Stage I application for the INCATE Selection Committee. If not, we offer feedback as to why your venture is not yet ready to apply for Stage I.
Stage I: The INCATE Selection Committee meets to review Stage I applications using criteria such as:
- Medical need
- Innovation potential
- Likelihood of equitable access
- Team
- Likelihood of developing a significant investment case within 24 months
- INCATE’s ability to help
Stage II: The INCATE Selection Committee meets to review Stage II applications and funding requests based on the above criteria and progress made in Stage I.
Check out the INCATE portfolio here!
No, both incorporated and unincorporated companies are welcome to apply.
No, you can be based anywhere in the world.
Your initial application should contain non-confidential material.
You will only be asked to share confidential material after completing a non-disclosure agreement (NDA.) Any confidential material you provide is shared with the INCATE Selection Committee and their representatives. When necessary, a bilateral NDA between your entity and INCATE — including consultants and select members of the INCATE Selection Committee — can be made.
To get started with your application, please contact the INCATE team at scoutingteam@incate.net.
No, the INCATE team is virtual. However, we can connect you to facilities where necessary.
No, working with INCATE does not affect your intellectual property.
INCATE does not provide follow-up funding. We aim to connect ventures with our community of investors, industry partners, and supporting partners who can provide additional support to ventures after they have built an investable case with INCATE.
Yes, the INCATE team is thrilled when our ventures obtain additional funding. In this case, you can choose to continue working with INCATE; however, INCATE funding may no longer be relevant.
No. INCATE advice and funding is provided at no cost and with no dilution.
No. We hope that you are able to find a fruitful collaboration with partners in our network, but there is absolutely no obligation to do so.
We hope all INCATE ventures will continue to be part of our community and give back to the next generation of innovators, but there is no obligation to do so.
We hope that during Stage II you are able to produce enough evidence to get support from other members of the ecosystem supporting the fight against drug-resistant bacterial infections such as the Industry Partners in the INCATE Selection Committee, Carb-X, GARDP, non-dilutive funding or equity investment.
INCATE does not support:
- Basic research
- Devices
- Diagnostics
- Digital tools
- Educational projects
- Late stage products


